In Israel, routine breast cancer screening still begins at age 50 — but as Hadassah experts warn, for many women that’s far too late.
A new feature in Yedioth Ahronoth (“7 Days” supplement) brings national attention to this urgent issue, spotlighting the leadership of Prof. Shani Paluch-Shimon, Head of the Breast Oncology Unit at Hadassah, and Prof. Tanir Allweis, Head of the Breast Division at Hadassah. Together, they present breakthrough recommendations that could reshape breast cancer detection and prevention across the country:
-Personalized risk assessments at ages 25–30, repeated every five years
-Risk questionnaires to guide referrals to breast cancer specialists
-Early identification of BRCA and other genetic mutations
-Tailored monitoring based on individual risk profiles
-Mammography beginning at 50 for women without symptoms or high-risk factors
These insights reflect Hadassah’s long-standing commitment to advancing women’s health and pioneering precision medicine.
We thank One in Nine and journalist Sarit Rosenblum for helping raise awareness, and we salute all the Hadassah experts leading the way in bringing earlier, more personalized screening to women everywhere.
At the Sharett Oncology Institute at Hadassah, we are proud to support these recommendations and continue working tirelessly to integrate the most advanced approaches in early detection and cancer care.